Masahiro Tsuboi

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Masahiro Tsuboi

Mar 18, 2025, 08:51 | Blog

Matt Hellmann: The detection of MRD by assaying ctDNA in patients with cancer

Matt Hellmann, Vice President of Early Oncology Development at AstraZeneca, shared an article Roy S.…

Jan 6, 2025, 09:48 | Insight

Amy Moore: PD-1/VEGF combos are a strategy to watch in lung cancer

Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a…

Dec 20, 2024, 14:12 | Science

Yuji Uehara: Resistance to osimertinib in EGFR-mutated LUAD

Yuji Uehara, Medical Oncologist, National Cancer Center, Japan, shared a post on X about a recent…

Nov 22, 2024, 22:09 | Insight

5 papers about Lung Cancer suggested by Stephen Liu

Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…

Oct 13, 2024, 22:27 | Insight

Stephen Liu: Analysis of locoregional relapse after segmentectomy in JCOG0802

Stephen Liu shared a post on X: “Analysis of locoregional relapse after segmentectomy in JCOG0802.…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023